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The toxicity of oxygen and nitrogen reactive species appears to be merely the tip of
the iceberg in the world of redox homeostasis. Now, oxidative stress can be seen as
a two-sided process; at high concentrations, it causes damage to biomolecules, and
thus, trypanosomes have evolved a strong antioxidant defense system to cope with
these stressors. At low concentrations, oxidants are essential for cell signaling, and in
fact, the oxidants/antioxidants balance may be able to trigger different cell fates. In this
comprehensive review, we discuss the current knowledge of the oxidant environment
experienced by T. cruzi along the different phases of its life cycle, and the molecular
tools exploited by this pathogen to deal with oxidative stress, for better or worse.
Further, we discuss the possible redox-regulated processes that could be governed by
this oxidative context. Most of the current research has addressed the importance of
the trypanosomes’ antioxidant network based on its detox activity of harmful species;
however, new efforts are necessary to highlight other functions of this network and the
mechanisms underlying the fine regulation of the defense machinery, as this represents
a master key to hinder crucial pathogen functions. Understanding the relevance of this
balance keeper program in parasite biology will give us new perspectives to delineate
improved treatment strategies.
Keywords: Trypanosoma cruzi, stage-specific oxidants, antioxidant network, regulation, redox-dependent
mechanisms
INTRODUCTION
Chagas disease (ChD) is one of the most important neglected tropical diseases in South and Central
America and in Mexico. It is estimated that 6–7 million people are infected with Trypanosoma
cruzi (T. cruzi), and∼300,000 new cases of ChD emerge each year that account for >10,000 deaths
per year1 During last two decades, ChD cases have also been reported in non-endemic countries
(e.g., United States and Canada), Western Pacific region, and Europe (reviewed in Schmunis, 2007;
Albajar-Vinas and Jannin, 2011; Tanowitz et al., 2011), primarily due to immigration of seropositive
individuals from endemic countries. However, in the Southern US, the natural cycle of T. cruzi
transmission is evidenced with the detection of high rate of infection in dogs (Curtis-Robles et al.,
2017, 2018) and autochthonous cases of ChD in humans (Garcia et al., 2017).
1World Health Organization (WHO) | Epidemiology, http://www.who.int/chagas/epidemiology/en/
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Two drugs, benznidazole and nifurtimox, are currently
available for the treatment of patients diagnosed early after
T. cruzi infection, but these drugs have limited efficacy in
the chronic disease phase (Morillo et al., 2015). Further, these
drugs have several side effects, and are not recommended
for persons with neurological and psychiatric disorders or
some degree of kidney failure, and for pregnant women
(reviewed in Patterson and Wyllie, 2014). Several vaccines
are in the experimental stage (reviewed in Rodríguez-Morales
et al., 2015; Rios et al., 2019) even though none of these
are yet available to prevent or control human T. cruzi
infection. Thus, new prophylactic and therapeutic strategies
for control of T. cruzi infection and chronic ChD are
urgently needed.
T. cruzi is an intracellular kinetoplastid parasite with a
complex life cycle that goes through several biochemical and
morphological changes during its transit through the vector and
mammalian host. Remarkably, T. cruzi can potentially infect
1000’s of vertebrate species, and at least 40 invertebrate species
(Teixeira et al., 2009). This parasite’s tremendous adaptability
to infect a wide variety of hosts ensures its survival in the
sylvatic and domestic cycles. An example of the pathogen’s
plasticity can be found in the reactive species management
system used by T. cruzi to keep homeostasis and ensure redox-
dependent pathways.
T. CRUZI EXPOSURE TO OXIDANTS IN
INSECT VECTORS
Oxidant Stressors in the Triatomine Vectors
T. cruzi faces a variety of oxidative stressors of internal and
external origin during its replication and differentiation in the
insect (Figure 1). Briefly, after being ingested by triatomines
with a blood meal, parasite goes through an active binary
division as an epimastigote in the insect gut. Once the
nutrients available for parasite proliferation become limited,
epimastigote forms move to the posterior midgut, adhere to
the wax cover of the rectal cuticle by hydrophobic interactions,
and undergo metacyclogenesis. During parasite’s replication
and passage through the vector’s intestinal tube, significant
amount of oxidants are produced by the triatomine’s immune
system (Figure 1A) (Ursic-Bedoya and Lowenberger, 2007). It
is suggested that triatomine recognition of pathogen-associated
molecular patterns (PAMPs) triggers innate immunity as well as
humoral and cellular protection (reviewed in Azambuja et al.,
2016). Briefly, the gut lumen is a prime site for the production
of immune effectors including reactive oxygen species (ROS) and
reactive nitrogen species (RNS) (Garcia et al., 2007, 2010; Genta
et al., 2010) by a pool of enzymes. Nitric oxide synthase (NOS)
was firstly identified through its cross-reaction with human
NADPH oxidase p67phox antibody (Whitten et al., 2001), and
its expression and activity in R. prolixus was later confirmed
by 2,3-diaminonapthalene fluorescence-based assay that detects
NO (Whitten et al., 2007). Other enzymes, namely dual oxidase
(DUOX) and NADPH oxidase (NOX), produce superoxide
radical (O2•−), and the latter can dismutate to hydrogen
peroxide (H2O2) or react with nitric oxide (NO) to produce
peroxynitrite (ONOO−) (Ha et al., 2005; Azambuja et al.,
2016). The phenoloxidase (PO) cascade, a hallmark immune
component of insects, is also present in triatomines leading to the
production of toxic quinones, melanin, and some intermediates
of reactive oxygen species (ROS) and reactive nitrogen species
(RNS) to encapsulate and kill the pathogens (reviewed in Flores-
Villegas et al., 2015). PO activity was increased after vector
infection with T. cruzi Dm28c strain though it had no effect
on parasite viability (Castro et al., 2012), and therefore, its
function as a driver of innate immunity against T. cruzi was
not established. Moreover, these authors postulated that parasite-
induced PO modifies vector immune responses to decrease
the gut microbiota and favor parasite development in the
insect gut.
In addition to vectorial oxidants, epimastigotes andmetacyclic
trypomastigotes are exposed to other compounds like heme
(ferriprotoporphyrin-IX) and heme breakdown products in the
midgut of the insect; produced by degradation of hemoglobin
that is the most abundant protein in mammalian blood. At
an estimated concentration of 10mM blood heme (bound
to hemoglobin), triatomine midgut is believed to carry toxic
amounts of heme during digestion of a single blood meal
(Graça-Souza et al., 2006). Free heme, even at 50–100µM
concentration, is a toxic molecule due to its ability to generate
ROS (Gutteridge and Smith, 1988) catalyzing the oxidation
of proteins, the formation of cytotoxic lipid peroxides via
lipid peroxidation and damaging DNA (reviewed in Kumar
and Bandyopadhyay, 2005). Nevertheless, triatomine vectors
exploit heme crystallization into hemozoin as a prime redox
regulator mechanism that protects the insect itself, but also
promotes parasite infection (Ferreira et al., 2018). Therefore,
in this context, free heme toxicity would be mitigated.
T. cruzi genome lacks the genes/proteins required for the
biosynthesis of heme (El-Sayed et al., 2005); however, it is
an essential cofactor that T. cruzi must intake from the
host. It was demonstrated that heme and its breakdown
products promote proliferation in T. cruzi epimastigotes (Lara
et al., 2007). Strikingly, T. cruzi insect stage is able to
withstand 1mM hemin—a concentration known to disrupt
phospholipid membranes—without any obvious toxic effect
(Lara et al., 2007). Nogueira et al., also described that heme
proliferative phenomenon was accompanied by a marked
increase in ROS formation in epimastigotes (Nogueira et al.,
2011, 2015). It was proposed that heme-induce transient
oxidative stress drives the epimastigote proliferation through
activation of calcium-calmodulin-dependent kinase II (CaMKII)
(Souza et al., 2009; Nogueira et al., 2011). Thus, T. cruzi
epimastigote can avoid heme toxicity, and instead use it as a
signaling molecule for its proliferation in the insect midgut
(Lara et al., 2007; Paes et al., 2011; Nogueira et al., 2017).
Oxidants Produced by Insect Stage
Parasite
T. cruzi also produces oxidants during its replication and
differentiation in the insect midgut. ROS production in T. cruzi,
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FIGURE 1 | ROS and RNS are produced throughout the life cycle of Trypanosoma cruzi. (A) Triatomines respond to T. cruzi infection and replication by up regulation
of nitric oxide synthase (NOS), dual oxidase (DUOX), and NADPH oxidase (NOX) that directly produce nitric oxide (NO) and superoxide radical (O2•
−); and NO and
O2•
− may produce highly stable hydrogen peroxide (H2O2) and highly toxic peroxynitrite (ONOO
−). Further, upon uptake of blood meal by the insect, epimastigotes
are exposed to great amounts of heme, a highly oxidant molecule. Parasite itself generates endogenous oxidative molecules produced by its electron transport chain
(ETC) and the oxidation of amino acids as carbon source. (B) When metacyclic trypomastigotes are transferred from bug to mammalian host, they first encounter the
ubiquitous oxidants present in bloodstream, e.g., hemoglobin and Fe2+ released from damage cells. When parasite invades the immune cells, such as macrophages,
it is exposed to a stronger oxidative/nitrosative stress sustained by inducible NOS (iNOS) and NOX2 in phagolysosome. As an intracellular amastigote, parasite
replicates in the host cell cytoplasm and generates ROS, primarily because it prefers oxidative metabolism of amino acids and fatty acids over glycolysis. If parasite
gets to infect a non-immune cell (e.g., cardiac myocyte), ROS continue to be present due to mitochondrial dysfunction of ETC at complex I and complex III.
in general, is closely related to nutrients metabolism in
each developmental stage. The epimastigote stage relies on
oxidation of L-proline, L-histidine, and L-glutamine for energy
supply. These amino acids are released from digestion of
blood proteins being abundantly present in the hemolymph
and tissue fluids of the hematophagous vectors (Cazzulo,
1984; Bringaud et al., 2006). L-alanine, is produced as a
metabolic end product by T. cruzi when it grows in a
medium rich in glucose and amino acids, but it can also
be taken up and oxidized to CO2 delivering electrons to
electron transport chain (ETC) (Girard et al., 2018). Thus,
amino acids oxidation fuels respiratory complexes and oxidative
phosphorylation for ATP generation; however, during this
process, electron leakage to O2 can also result in O2•− formation,
possibly supporting an oxidative environment (Figure 1A).
Further, Nogueira et al. (2017) showed that presence of heme
during in vitro culture of T. cruzi, induced mitochondrial
membrane hyperpolarization and an increase in endogenous
O2•− production. As we mentioned previously, the heme-
induced mitochondrial ROS were beneficial in promoting
epimastigote survival and proliferation. Conversely, urate-like
antioxidants produced in the hemolymph were found to
arrest epimastigotes’ growth and promote differentiation of
epimastigotes to metacyclic infective form (Nogueira et al.,
2015). To sum up, T. cruzi epimastigotes appear to utilize the
components of oxidative stress for their growth in the insect
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gut, and then for switching to metacyclogenesis and be ready for
transition to mammalian infective stage.
T. CRUZI EXPOSURE TO OXIDANTS IN
THE MAMMALIAN HOST
Exposure to Oxidative and Nitrosative
Stress in Immune Cells
Triatomines release infective, non-replicative, metacyclic
trypomastigotes in feces while taking the next blood meal on a
mammalian host. Once trypomastigotes enter the blood stream
of the vertebrate host, they quickly infect a variety of cells and
differentiate to the replicative amastigote stage. During this
process, the parasite has to deal with a second wave of oxidative
stress. Studies in mice and humans show that innate and adaptive
immune responses, involving macrophages, neutrophils, natural
killer cells, B and T lymphocytes, should control the parasite
through the production of ROS/RNS, proinflammatory TH1
cytokines, trypanolytic antibodies, and cytotoxic T lymphocytes’
activity; readers are referred to excellent reviews on this topic
(Junqueira et al., 2010; Machado et al., 2012; Cardillo et al.,
2015; Bonney et al., 2019). A thorough analysis of all the
components of natural and experimental innate and adaptive
immunity against T. cruzi infection is beyond the scope of
this article. Herein, we will focus on macrophages that offer
the first line of defense upon parasite engulfment (discussed
in Lopez et al., 2018).
T. cruzi (metacyclics and trypomastigotes) can actively
invade a variety of non-immune and immune cells and
also may be phagocytosed by macrophages and dendritic
cells (reviewed in Walker et al., 2013). The parasite uptake
triggers an almost immediate increase in the expression
of inflammatory cytokines followed by delayed and subpar
production of O2•− and NO in macrophages (Koo et al.,
2018). As in the vector host, in infected macrophages also,
inducible NADPH oxidase (NOX2) produces O2•− that can
be transformed spontaneously or enzymatically by superoxide
dismutases (SODs) to H2O2, and the latter is dismutated by
GPx and catalase (Figure 1B) (Gupta et al., 2011). Likewise,
inducible nitric oxide synthetase (iNOS) produces NO that can
react with O2•− and generate ONOO− in infected macrophages.
Although ONOO− has a short life, it is the most powerful
cytotoxic effector produced by macrophages for parasite killing
(Alvarez et al., 2011). Yet, it must be mentioned that the
proinflammatory cytokines and the oxidative and nitrosative
stress are capable of controlling, but not preventing the
dissemination of virulent parasite strains from macrophages
(reviewed in Lopez et al., 2018; Koo and Garg, 2019). This
is, in part, attributed to the ability of the virulent isolates
of T. cruzi to orchestrate their antioxidant system and allow
sub-par and delayed activation of oxidative/nitrosative burst
in the host immune cells (Piacenza et al., 2009b; Zago et al.,
2016). Others have indicated that oxidative stress produced in
response to T. cruzi infection correlates with higher parasite
burden in an animal infection model, pointing to oxidative
environment as an enhancer of infection (Paiva et al., 2012).
In agreement with this finding, treatment with compounds,
such as iron chelator desferrioxamine and melatonin that also
have antioxidant capacity reduced the parasite proliferation
(Arantes et al., 2007; Santello et al., 2007). However, it was
a correlative observation, and authors did not clarify if the
observed proliferative effects on the parasite were indeed due
to antioxidant nature of these drugs. Regardless, the current
literature indicates a dual role of ROS/RNS in parasite control
vs. parasite proliferation and spreading in the mammalian host.
Immune oxidative response can, in fact, control parasite infection
whereas at lower levels, an oxidant environment may promote
pathogen replication.
Exposure to Oxidative Stress in
Non-immune Cells
Parasite is also exposed to cytotoxic molecules in non-immune
cells, primarily because a wide variety of ROS and RNS are
continuously formed as byproducts of aerobic metabolism.
In general terms, mitochondrial ETC coupled with oxidative
phosphorylation accounts for 85–90% of the O2 consumed
in a cell. Up to 3% of the consumed O2 is incompletely
metabolized, and results in O2•− release (Silva et al., 2011;
Wang and Hai, 2016). The heart is particularly dependent on
mitochondria to produce the energy required for its contractile
activity, and mitochondria represent up to 30% of the total
volume of cardiomyocytes, providing 90% of the cellular ATP
energy through oxidative phosphorylation. In cardiomyocytes
infected by T. cruzi, and in the myocardium of chronically
infected animals (Mukherjee et al., 2003; Wen and Garg, 2004)
and ChD clinically symptomatic patients (Cunha-Neto et al.,
2005; Wen et al., 2006; Wan et al., 2012; Dhiman et al.,
2013), mitochondrial dysfunction was well-documented by us
and other researchers. Specifically, activities of the respiratory
complex I and complex III were compromised and resulted
in a significant increase in electron leakage to O2 and O2•−
production in mitochondria of infected cardiomyocytes and
ChD hearts (Vyatkina et al., 2004; Gupta et al., 2009). In vivo
studies in mice and rats showed that mitochondrial defects
persisted beyond the acute phase of infection, correlating with
high mitochondrial ROS (mtROS) levels during chronic disease
phase (Wen et al., 2008, 2017; Wan et al., 2016). Further, the
increase in mtROS production correlated with a decline in
the expression and activity of the mitochondrial antioxidant
enzyme Mn+2 superoxide dismutase (MnSOD), and a decline
in the cytosolic glutathione peroxidase (GPx) activity and GSH
content in the myocardium of chronically infected animals (Wen
and Garg, 2004) and in ChD patients (Pérez-Fuentes et al.,
2003; Wen et al., 2006; de Oliveira et al., 2007; Wan et al.,
2012; Dhiman et al., 2013), thus revealing the persistence of a
pro-oxidant milieu along the infection process. These studies
point to the role of ETC as an important source of oxidant
species in non-immune cells, especially in cardiomyocytes
that are one of the main target cells invaded by T. cruzi
(Figure 1B). Garg and co-workers have proposed that a lack
of appropriate antioxidant and repair response result in self-
perpetuating mitochondrial dysfunction and ROS production
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in the heart (reviewed in Lopez et al., 2018; Bonney et al.,
2019). This mtROS production in Chagas heart can provide a
defense against parasite persistence; however, it also signals the
fibrotic gene expression and contribute to evolution of chronic
cardiomyopathy (Wan et al., 2012; Wen et al., 2017).
Non-enzymatic Oxidative Stress
As in the insect stage, T. cruzi is also exposed to the non-
enzymatic oxidative species in themammalian host. For example,
essential metals, such as iron, zinc, and copper play a critical role
in many biological processes. The Fe+2/Fe+3 and Cu+2/Cu+3 act
as electron donor/acceptor and play a vital role in catalysis of a
variety of enzymatic reactions that involve an electron transfer.
Specifically, up to 70% of the body iron is present in red blood
cells (RBCs) in the form of hemoglobin and in muscle cells as a
component of myoglobin (Winter et al., 2014). In these tissues,
iron is also present in iron-sulfur (Fe-S) clusters, and it serves
as a cofactor to support ETC, respiration, and oxygen transport
(reviewed in Rouault, 2012). Likewise, copper is the cofactor of
metabolic enzymes (e.g., cytochrome c oxidase in mitochondria,
CuZnSOD in cytosol) and it catalyzes the enzymatic activity of
key enzymes of the secretory pathway (reviewed in Polishchuk
and Lutsenko, 2013; Baker et al., 2017). However, these metals
are redox active, and in an oxidative environment undergo
redox-cycling reactions leading to exacerbated production of
free radical species. The toxicity of iron, and, by association, of
copper, is driven by their ability to reduce peroxides, via Fenton
chemistry, into highly reactive hydroxyl radical that subsequently
reacts at diffusion-limited rates with various biomolecules (Valko
et al., 2016; Sánchez et al., 2017). Further, Fe-S clusters are
preferred targets of O2•−, and their oxidation leads to Fe+2
release that then can feed Fenton reaction and ROS production
(Fridovich, 1995).
Heme and free iron released by dying RBCs and damaged
muscle cells may also generate oxidative stress (Beard, 2001;
McCord, 2004). Thus, it could be speculated that the breakdown
of metal ion homeostasis can expose T. cruzi to iron (and up to
some extent copper) in the blood stream as well as in muscle
cells and tissues that are the preferred site of T. cruzi replication.
Skeletal muscle and heart may also accumulate considerable
amounts of iron as is noted in brain, liver and other tissues,
and there is evidence that increased iron storage correlates with
ROS formation in tissues (Yoshiji et al., 1992; Barollo et al.,
2004; Shoham and Youdim, 2004; Sullivan, 2004). Cytosolic
ferritin (binds up to 4,500 iron atoms for storage) may be a
source of free iron when it undergoes degradation in response
to stress (reviewed in Philpott et al., 2017). Thus, we propose
that endogenous iron storage in muscle cells and tissues may
also expose intracellular amastigotes to oxidative stress. Still,
many reports describe the requirement for a mild oxidizing
environment for the efficient iron mobilization, which in turn
enhances intracellular parasite growth. Hence, it is suggested that
depletion of intracellular iron stores in host cells could impair
T. cruzi replication. Conversely, host responses transferring iron
to the intracellular sites of T. cruzi replication may enhance
parasite pathogenicity (reviewed in Andrews, 2012; Paiva et al.,
2018). Future studies are needed to clearly define the role of iron
metabolism and redox signaling in parasite proliferation.
ROS as a Byproduct of
Trypomastigote/Amastigote Metabolism
ROS generation within T. cruzi is closely related to available
energy sources. In contrast to epimastigote forms of T. cruzi
that rely on amino acids metabolism in the vector host, infective
trypomastigotes have access to abundant glucose (up to 5mM)
in bloodstream of the vertebrate host. Not surprisingly then,
trypomastigotes utilize glucose as a preferred carbon source for
their energy requirement in the mammalian host (Silber et al.,
2009). Glucose fermentation in trypomastigotes’ glycosome—
a peroxisome-like organelle—produces CO2, succinate, and
acetate (reviewed in Bringaud et al., 2006; Michels et al.,
2006), and provides substrates for oxidative phosphorylation.
The bioenergetics metabolism in the intracellular, replicative,
amastigote stage remains controversial. Some investigators have
indicated that the intracellular form of the parasite arrests the
expression of glucose transporters (Silber et al., 2009), and
utilizes fatty acids and amino acids taken from the cell cytosol
to satisfy its energy needs (Engel et al., 1987; Silber et al.,
2009). Indeed, expression of enzymes needed for fatty acids
oxidation are increased in amastigote form of the parasite
(Atwood et al., 2005), thus suggesting a metabolic shift. However,
recent studies have employed a metabolic labeling approach to
show that T. cruzi infection modulates host cell metabolism and
stimulates cellular glucose uptake that can then be utilized by
parasite for its own replication in the host cytosol (Shah-Simpson
et al., 2017). These seemingly contradictory results could simply
suggest that intracellular parasites fuel their metabolism in a
flexible manner. Thus, while epimastigotes rely on amino acids
catabolism and mitochondrial respiration, trypomastigote—and
likely amastigote—parasite forms depend mostly on glycolysis
but sparingly use fatty acids or other sources of energy. If
such is the case, then they do not need to face a strong
endogenous ROS stress that otherwise is associated with high
mitochondrial activity.
Nevertheless, from a different line of evidence, Gonçalves
et al. (2011) have shown, through functional assessment
of mitochondrial metabolism, an increased generation of
H2O2 in the bloodstream trypomastigotes compared to the
epimastigote stage (Gonçalves et al., 2011). According to
these authors, during the parasite transformation from the
insect to infective trypomastigote form, mitochondrial organelle
undergoes remodeling that results in (a) increased activities
of the respiratory complex II and complex III facilitating
electrons’ entrance to the ETC, and (b) decreased expression and
activity of complex IV. This would promote the generation of
an “electron bottleneck,” favoring O2•− and H2O2 formation
(Gonçalves et al., 2011). In this scenario, it is argued that
even if trypomastigotes are more dependent on glycolysis than
oxidative phosphorylation for their energy need (Bringaud et al.,
2006; Silber et al., 2009), they may still be exposed to excessive
oxidative stress due to mitochondrial remodeling and increased
ROS production (Gonçalves et al., 2011).
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Drugs-Derived Oxidative Stress
Treatment with anti-parasite drugs, benznidazole (BZ) and
nifurtimox (NFX), also exposes the parasite to oxidative stress.
BZ is the preferred drug for the treatment of acute ChD. In this
sense, it is worthy of note that several BZ delivery platforms
and formulations are been assayed in pre-clinical studies (Scalise
et al., 2016; Santos Souza et al., 2017; García et al., 2018) and a
pediatric formulation of BZ is available since 20112, improving
dosing accuracy, safety, and adherence to treatment. Both BZ
and NFX are pro-drugs that are cleaved to their active form in
the parasite by nitroreductase type I (NTR-I) (Hall et al., 2011;
Hall and Wilkinson, 2012). It is suggested that the activated
BZ and NFX (and their metabolites), through direct binding to
trypanothione (T[SH]2, N1,N8-bisglutathionylspermidine) and
GSH, make these antioxidants unavailable for the parasite’s
defense (Maya et al., 1997; Trochine et al., 2014). Thus, BZ/NFX,
at appropriate concentration, would decrease the availability of
low MW thiols such that oxygen redox cycling-derived free
radicals, drug-derived free radicals, and reduced electrophilic
metabolites are accumulated and cause cytotoxic effects on
the parasite biomolecules (Maya et al., 1997). The activation
of BZ by NTR-I also generates DNA-toxic glyoxal adducts
in an oxygen-insensitive reaction (Hall and Wilkinson, 2012).
In the host, BZ promotes an adaptive response to oxidative
injury activating the nuclear factor-erythroid 2-related factor-
2 (Nrf2) and multidrug resistance associated protein 2 (MRP2)
(Rigalli et al., 2016). However, anti-parasite therapy is not always
successful because of varying degrees of susceptibility of different
parasite strains. This is probably, due to diverse mechanisms
such as differences in the thiol content, NTR-I downregulation
(Wilkinson et al., 2008), or deletion of copies of the gene
encoding prostaglandin F2α synthase (referred as old yellow
enzyme) that is involved in activating the anti-parasite drugs
(Murta et al., 2006). Nevertheless, at present, there are no drugs
clinically superior to NFX or BZ.
THE COMPLEXITY OF ROS AND RNS
CYTOTOXIC EFFECTS ON T. CRUZI
Before we discuss the cytotoxic effects of oxidative stress on
parasite, it should be mentioned that ROS and RNS are broad
terms that include free radical and non-radical active species with
different levels of toxicity. Effect of each active molecule depends
on its amount, reactivity, half-life, diffusion properties, and
biological interactions. Furthermore, it is well-established that
many of these species can give rise to secondary oxidants with
different reactivity and lifespan than the initial ones (reviewed
in Halliwell and Gutteridge, 2015). Overall, high concentrations
of reactive species produced by immune response, oxidative
metabolism, and other environmental factors create a complex
landscape of oxidative stress that the parasite has to deal with to
maintain redox homeostasis for its survival in diverse hosts.
One of the main targets of ROS is DNA. There are many
types of oxidative modifications noted in the sugar-phosphate
2Drugs for Neglected Diseases initiative (DNDi); https://www.dndi.org/
achievements/paediatric-benznidazole/
backbone and nitrogenous bases of DNA, and considering the
low reduction coefficient of guanine, this base is recognized
as the most susceptible nucleotide (David et al., 2007). Once
guanine is oxidized, it assumes a syn conformation called 8-
oxoguanine (8-oxoG) that mimics thymine, and thereby exerts
a strong mutagenic effect by transversion. Oxidized DNA is also
susceptible to nicks, and introduces single and double strand
DNA breaks (Cheng et al., 1992; Aguiar et al., 2013). While
double strand breaks are lethal if left unrepaired, oxidized bases
may be mutagenic, cytotoxic or both. Indeed, recent studies have
shown that exposure to H2O2 caused a 2-fold increase in the
frequency of mutations to T. cruzi DNA (Torres-Silva et al.,
2018), and it turned out to be cytotoxic to the pathogen (Zago
et al., 2016; Mesías et al., 2018). However, others have proposed
that oxidative DNA damage, along with the recently documented
8-oxoG lesion repair system in T. cruzi (Machado-silva et al.,
2016), were beneficial in enhancing the genetic diversity and
favored the selection of parasites capable of evading immune
system and develop drug resistance (Torres-Silva et al., 2018).
Further studies will be necessary to elucidate the levels and types
of oxidative DNA modifications that are cytotoxic to T. cruzi vs.
those that offer survival advantages to the parasite.
Reactive lipid species (RLS) within the membranes can be
formed enzymatically (e.g., by lipoxygenase and cyclooxygenase)
or through non-enzymatic lipid peroxidation and nitration
pathways (Gaschler and Stockwell, 2017). Major classes of
RLS include lipid aldehydes, α,β-unsaturated carbonyls, and
nitroalkenes (discussed in Esterbauer et al., 1991; Ayala et al.,
2014; Gaschler and Stockwell, 2017). Some of these are stable,
and can diffuse through cell membrane affecting membrane
functions, such as lipid–lipid interactions, ion gradients, fluidity
and permeability, thus, causing a major issue for cell homeostasis
(Skouta et al., 2014; Van der Paal et al., 2016; Agmon and
Stockwell, 2017; Agmon et al., 2018). Other RLS, e.g., 5-deoxy-
delta-12,14-prostaglandin J2 (15d-PGJ2), signal intracellular
receptor PPAR-γ to mediate resolution of inflammation (Agmon
and Stockwell, 2017). There is scarce evidence regarding the
generation of RLS and their role in T. cruzi; though some
investigators have reported that heme-induced ROS elicited lipid
peroxidation, 4-hydroxy-2-nonenal (4-HNE) adducts, and yet it
supported epimastigotes’ proliferation (Nogueira et al., 2011).
Proteins are also major targets of oxidation due to their high
concentration and reactivity with multiple oxidants (reviewed
in Davies, 2016). Proteins may undergo oxidative modifications
that are reversible (e.g., sulfenylation, nitrosylation, or s-
glutathionylation of cysteine residue) or irreversible (e.g.,
protein carbonylation and 3-nitrotyrosine formation); and these
oxidative modifications can affect protein function or protein-
protein interaction (Cai and Yan, 2013). Alternatively, self-
protein oxidative modifications could be exploited by the
parasite for signaling various pathways. Indeed, it was shown
that in presence of extracellular matrix that constitute the
cell surrounding layer crossed by the parasite for invasion
of host cells, pathogen undergoes selective S-nitrosylation and
tyrosine nitration (Pereira et al., 2015). These authors proposed
that T. cruzi actively modulates its nitrosylation allowing its
internalization into host cells.
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In summary, the complete extent of the effects of ROS/RNS
on T. cruzi is not fully disclosed. Yet, the killing of T. cruzi by
oxidative stress in immune cells and the generation of DNA-
toxic glyoxal and oxidative adducts by BZ are well-documented
(Maya et al., 2003; Wilkinson et al., 2011). Thus, the antioxidant
enzymes expressed by T. cruzi are essential for providing defense
against oxidative damage and allow the parasite to thrive in
oxidative conditions, discussed below.
A DISTINCTIVE ANTIOXIDANT SYSTEM IN
PARASITIC PROTOZOANS
Trypanothione (T[SH]2), a Unique
Derivative of Glutathione
T. cruzi antioxidant machinery relies on a low molecular weight
diglutathionyl-spermidine conjugate named T[SH]2 that is
analogous to glutathione (GSH) in most eukaryotes (Manta et al.,
2013) (Table 1). The production and consumption of T[SH]2
antioxidant is increased in bloodstream and intracellular stages of
the parasite (Ariyanayagam and Fairlamb, 2001; Ariyanayagam
et al., 2003). Firstly, biosynthesis of GSH substrate in protozoan
parasites is catalyzed by two enzymes. Gamma-glutamylcysteine
synthetase (GshA) ligates L-glutamate and L-cysteine to form
γ-glutamylcysteine; and in a second step glutathione synthetase
(GshB) forms a C-N bond between γ-glutamylcysteine and L-
glycine to produce GSH. The fluctuating concentrations of GSH
in human patient’s plasma and the significant decrease in plasma
GSH levels in seropositive patients (Dhiman et al., 2013) suggest
that T. cruzi synthesizes its own GSH as well as utilizes host’s
GSH to supply the needed substrate for T[SH]2 production.
Next, the trypanothione synthetase (TryS) enzyme catalyzes an
ATP-dependent two-step reaction in which two GSH molecules
and a polyamine (spermidine) are used to synthesize T[SH]2 in
cytosol of the parasite (Oza et al., 2002). The T[SH]2 molecules
deliver reducing equivalents to peroxidases and other enzymes
responsible for neutralizing ROS, and the oxidized form of
trypanothione is reduced by trypanothione reductase (TryR) in
presence of NADPHproduced by the pentose phosphate pathway
(PPP) (discussed below and reviewed in Irigoín et al., 2008).
Considering their essential function in maintaining reduced
T[SH]2, TryS, and TryR are attractive drug targets for control
of trypanosomes.
The redox potentials of T[SH]2 (2,242mV) and GSH
(2,230mV) are very similar, though T[SH]2 (pKa 7.4) and
GSH (pKa 8.7) exhibit dramatic differences in their pKa values
(Moutiez et al., 1994). Since rate constants for thiol-disulfide
exchange is optimal when the thiol pKa value is equal to the
solution pH value, T[SH]2 is more reactive than GSH under
physiological conditions. Furthermore, dithiols are kinetically
superior than the monothiols (Dormeyer et al., 2001) in reducing
intramolecular disulfides (Table 1). Thus, it is believed that
T[SH]2 serves as a major antioxidant molecule in trypanosomes
and GSH is primarily consumed to produce T[SH]2 in T. cruzi
(Olin-Sandoval et al., 2012).
Besides T[SH]2 and GSH, insect stage epimastigotes utilize
a significant amount of N1-methyl-4-mercaptohistidine or
ovothiol A as antioxidant. Ovothiol A has non-enzymatic
reactivity with H2O2; yet its neutralizing activity is considerably
less than that of T[SH]2. Therefore, under physiological
conditions, it is unlikely that ovothiol A plays a major role in the
metabolism of hydrogen peroxide (Ariyanayagam and Fairlamb,
2001). T. cruzi also possesses significant levels of vitamin C
(ascorbate) antioxidant. Unlike humans and other vertebrates,
parasite genome encodes for complete ascorbate biosynthesis
pathway, and it is speculated to be localized in glycosome
(Wilkinson et al., 2005) and serve as an alternative ROS scavenger
in T. cruzi and other trypanosomes (Wilkinson et al., 2002a).
A Network of Antioxidant Enzymes in
T. cruzi
Trypanosomes utilize a highly developed network of peroxidases
and superoxide dismutases to control ROS and RNS (reviewed
in Irigoín et al., 2008; Piacenza et al., 2009a; Machado-
silva et al., 2016). Briefly, trypanosomes have equipped their
mitochondria, the site of electron release to oxygen and O2•−
formation, with a solid antioxidant defense. These include
(a) two iron-dependent, superoxide dismutases (FeSODA and
FeSODC) that convert O2•− into H2O2; and (b) a two-
cysteine mitochondrial tryparedoxin peroxidase (mTXNPx)
capable of rapidly detoxifying H2O2 and ONOO− (Ismail
et al., 1997; Piñeyro et al., 2011a; Phan et al., 2015). The
endoplasmic reticulum (ER) utilizes oxidizing environment
for the formation of the disulfide bonds required for the
folding of proteins into functionally active forms (Malhotra
and Kaufman, 2007). Persistent oxidative stress can result in
protein unfolding and cell death (Sano and Reed, 2013). Whether
trypanosomes face excessive oxidative stress in the ER is not
experimentally documented, yet two distinct peroxidases are
localized in the ER in T. cruzi, namely, ascorbate peroxidase
(APx) that utilizes ascorbate to remove H2O2, and non-
selenium glutathione peroxidase II (nsGPx-II) that detoxifies
hydroperoxides (Wilkinson et al., 2002c). Others have shown that
APx is localized on the ER and mitochondrial membranes in
all parasites stages but also on plasma membrane in infective
stages (Hugo et al., 2017), thus implying that APx may play
a role during parasite invasion. Similarly, trypanosomes utilize
a highly specialized peroxisome, labeled as glycosome, for
important metabolic functions, including glycolytic pathway,
pentose-phosphate pathway, β-oxidation of fatty acids, purine
salvage, and biosynthetic pathways for pyrimidines, ether-lipids
and squalenes (Haanstra et al., 2016). Accordingly, T. cruzi
has evolved to localize FeSODB2 and nsGPx-I antioxidant
enzymes in the glycosomal compartment (Wilkinson et al., 2000,
2002b; Patel et al., 2010). It was demonstrated that nsGPxs
do not metabolize H2O2, yet, nsGPx-I and -II overexpression
in trypanosomes conferred protection from exogenous H2O2,
thus suggesting their role in detoxifying the secondary products
of lipid peroxidation reactions (Wilkinson and Kelly, 2003).
However, the relevance of nsGPx in the infective stage of T. cruzi
is unknown.
Finally, cytosolic tryparedoxin peroxidase (cTXNPx),
FeSODB1, and GPx-I maintain the redox balance in parasite’s
cytoplasm. Experiments with recombinant enzyme and FeSOD-
overexpressing parasites revealed its importance in virulence
and pathogenicity, safeguarding the parasite from host-derived
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0.25–0.95 nmol/108 bloodstream trypomastigotes;
0.12 nmol/108 amastigotes (Ariyanayagam and Fairlamb,
2001; Ariyanayagam et al., 2003)
Glutathione (ubiquitous monothiol among eukaryotes) and trypanothione (a kinetoplastid-specific dithiol) are synthesized by parasites’ antioxidant machinery, and these molecules play
a key role in distribution of reducing equivalents along the antioxidant network. Even when they have similar characteristics, T[SH]2 is considered a kinetically superior antioxidant.
cytotoxic oxidants (Piacenza et al., 2008; Arias et al., 2013;
Martínez et al., 2019). The expression levels of cTXNPx as
well as of mTXNPx are increased in infective and intracellular
stages of the parasite (Zago et al., 2016); these two enzymes
work in concert to control the cytosolic and mitochondrial
oxidative stress (De Figueiredo Peloso et al., 2011), and are
extensively studied for the design of anti-parasite therapies.
Lastly, annotation of the parasite genome has revealed that
T. cruzi lacks catalase, glutathione reductase, thioredoxin
reductase, and selenium-dependent glutathione peroxidases
(El-Sayed et al., 2005).
Tryparedoxin Intermediates
An important mediator for the T[SH]2-fuelled redox reactions
is the dithiol protein and oxidoreductase named tryparedoxin
(TXN) (Lopez et al., 2000). In T. cruzi, two isoforms TXN-
I and TXN-II, have been identified. TXNs are considered
members of the thioredoxin family of proteins based on the
comparative sequence analysis, presence of common motif
WCPPC of the oxidoreductase superfamily in their catalytic
center and some other features that are conserved throughout
this type of oxidoreductases. However, TXNs display many
differences from the host thioredoxins, and are considered
to be unique proteins of trypanosomatids and appropriate
targets for anti-parasite drug design (Comini et al., 2007).
TXNs transfer reducing equivalents from T[SH]2 to redox
pathway that include cTXNPx, mTXNPx, and nsGPx-I involving
thiol/disulfide exchange (reviewed in Arias et al., 2013). In T.
cruzi, TXN-I is localized in cytosol, and TXN-II is anchored
to outer membrane of mitochondria, ER, and glycosomes via a
C-terminal hydrophobic tail (Arias et al., 2013). TXN-II is also
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able to transfer reducing equivalents to low molecular weight
disulfides (e.g., GSSG, cystine, dehydroascorbate) and catalyze
the reduction of S-nitrosoglutathione and S-nitrosocysteine, and
thus, regenerate the reduced form of key metabolites in T. cruzi
(Arias et al., 2013).
Besides their role in oxidant recycling, new possible functions
of TXNs were delineated by interactomics. For example, TXN-
I was predicted to interact with other oxidative metabolism
components, cysteine and methionine related pathways, as
well as protein translation and degradation partners (Piñeyro
et al., 2011b). For TXN-II, different interactors were identified
under physiological and oxidative stress conditions, and it
was suggested to influence the proteins involved in energy
metabolism and cytoskeleton and protein translation (Arias et al.,
2015; Dias et al., 2018). Further studies will be required to
demonstrate the biological significance of TXNs in T. cruzi
adaptation to different environmental conditions imposed by its
life cycle.
REDOX-DEPENDENT PROCESSES
In recent years, several scientists have identified new roles of
redox homeostasis. It is suggested that ROS (e.g., H2O2) at low
levels serve as second messenger, and low MW thiols monitor
the cellular redox state and play a decisive role in triggering
physiological pathways like programmed cell death and DNA
replication (Remacle et al., 1995; Gonzalez-Gonzalez et al.,
2017; Lorenzen et al., 2017; Phull et al., 2018). Besides, thiol
peroxidases appear to be important players in redox signaling
processes. In yeast, it is further demonstrated that these enzymes
are involved in active peroxide signal distribution via disulfide
exchange (Delaunay et al., 2002; Veal et al., 2004; Okazaki
et al., 2005; Iwai et al., 2010). Similarly, in mammals, there are
several examples showing that peroxiredoxins (PRDXs) function
as peroxide receptors and transduce signal to target protein
circuits involved in cell growth, differentiation, apoptosis, and
carcinogenesis (Neumann et al., 2003; Han et al., 2005; Edgar
et al., 2012; Jarvis et al., 2012; Kil et al., 2012; Sharapov and
Novoselov, 2019). Yet, it is not fully elucidated how peroxidase-
dependent mechanisms would operate in T. cruzi. Despite the
knowledge gaps, antioxidant network not only protects the
parasite from ROS and RNS, but also supports cellular redox-
regulated processes (Figure 2).
Programmed Cell Death (PCD)
Readers are referred to excellent recent reviews describing the
signaling events and methods of cell death in higher eukaryotes
(Green and Llambi, 2015; Weinlich et al., 2017; D’Arcy, 2019).
Briefly, cell death/cell removal occurs by three main modes:
apoptosis (type I), autophagy (type II), and necrosis (type III)
(Green and Llambi, 2015). In particular, apoptosis describes
the death of a cell mediated by an intracellular program
that can be triggered by exogenous or endogenous stimuli.
Some common features of apoptosis include (a) translocation
of phosphatidylserine to outer side of the plasma membrane,
(b) annexin and calreticulin exposure on the cell surface, and
(c) morphological changes, including condensation of the cell
cytoplasm, nuclear DNA fragmentation, dissociation of cell
organelles, and disruption of the cell plasma membrane. The
boundary between type I and type II cell death is not entirely
clear; apoptosis may begin with autophagy (or vice versa), and
blockage of caspase activity may lead to cell death by type II mode
than the type I mode. The switch between type I and type III
modes of cell death is determined by a variety of factors, discussed
elsewhere (Elmore, 2007; Weinlich et al., 2017). Other types of
regulated cell death include necroptosis, pyroptosis, ferroptosis,
phagoptosis, and entosis (reviewed in D’Arcy, 2019). Moreover,
new insights into these processes show that the border between
life and death is so tight that some of these unconventional
pathways can in fact promote survival. Remarkably, it was
also recently described that cells can recover from the brink
of apoptosis or necroptosis through new pathways defined as
resuscitation and anastasis (Gudipaty et al., 2018).
Trypanosomes exhibit several features of eukaryotic
cell apoptosis, including loss of mitochondrial membrane
potential, cytochrome c release, cell shrinkage, and DNA
fragmentation, although the exact mechanisms involved
in PCD of trypanosomatids and its biological relevance is
still under debate (De Souza et al., 2010; Dos Anjos et al.,
2016; Menna-Barreto, 2019). The classical caspases and Bcl-2
homologs were not found in trypanosomes, but meta-caspases
(TcMCA3 and TcMCA5) were described in T. cruzi (Laverriere
et al., 2012). TcMCA5-overexpressing T. cruzi epimastigotes
exhibited apoptosis-like phenotype in presence of fresh human
serum (Kosec et al., 2006). Further, T. cruzi epimastigotes
incubated in fresh human serum exhibited a decline in T[SH]2
and GSH levels, decreased mitochondrial aconitase activity,
and increased ROS levels (Piacenza et al., 2007). Others have
suggested that complement deposition on parasite membranes
leads to assembly of membrane attack complex (MAC) that
triggers Ca2+ influx/overload, disruption of mitochondrial
membrane potential, increase in mtROS production, and release
of mitochondrial molecules into cytosol, thus signaling apoptosis
and parasite death (Irigoín et al., 2009). Further, a recent study
showed that cardiomyocytes produce diffusible redox mediators
(e.g., H2O2) that promote PCD in amastigotes and control
intracellular proliferation of parasite (Estrada et al., 2018).
However, the expression of FeSODA antioxidant is increased
in infective trypomastigote and replicative amastigote forms
(Atwood et al., 2005), and it is possible that parasite utilizes
these antioxidants to evade death in the host cells. Indeed,
experimental overexpression of FeSODA arrested PCD in T.
cruzi (Piacenza et al., 2007), thus providing an experimental
proof for the relationship between PCD and antioxidant status in
T. cruzi. Summarizing, these studies suggest that parasite utilizes
antioxidant system to survive in the bloodstream and increase
its chances to invade and replicate in the cells of a vertebrate
host. Future studies will reveal the mechanistic utilization of
antioxidant network by T. cruzi to prevent its own death in
bloodstream and/or in phagocytes and non-immune cells.
Degradation Machineries
Eukaryotic cells utilize autophagy to degrade unwanted, aged
or damaged cellular material and release the nutrients (e.g.,
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FIGURE 2 | REDOX balance influences different parasite processes. Redox homeostasis is controlled by parasite’s antioxidant network, which is formed by enzymatic
and non-enzymatic-antioxidant molecules. Among the redox-influenced processes, parasite cell cycle was shown to be regulated by redox balance, i.e.,
epimastigote’s proliferation being induced by oxidative environment. Genomic DNA (gDNA) and kinetoplastid (kDNA) synthesis, as part of cell cycle, are also regulated
by redox state in trypanosomatids. Metacyclogenesis is another redox-regulated phenomenon, and some evidence suggest that antioxidants may promote
epimastigotes’ differentiation to metacyclic infective stage. Besides, over-expression of antioxidant enzyme FeSOD in T. cruzi offered enhanced parasite survival
through control of programmed cell death (PCD). Autophagy, a self-degradative process for the removal of organelles and proteins, could also be related to redox
balance in parasites. Autophagy is triggered by polyamines used as substrate by antioxidant enzymes, and this process is suggested to be associated
with metacyclogenesis.
amino acids and nucleotides) for self-preservation. Currently,
>40 AuTophaGy-related (ATG) proteins and other proteins that
participate in autophagy are known (Xie and Klionsky, 2007;
Inoue and Klionsky, 2010; Jin and Klionsky, 2014; Kuma et al.,
2017). The autophagy pathway involves several steps including,
(1) autophagy induction, (2) cargo selection and package, (3)
vesicle nucleation, (4) vesicle expansion and completion, (5)
retrieval, (6) fusion of the autophagosomewith lysosome vacuole,
and (7) vesicle breakdown (Zhao and Zhang, 2018). The readers
are referred to excellent reviews for further details of this pathway
(Xie and Klionsky, 2007; Chun et al., 2018).
In trypanosomes, though genes involved in cargo packaging
are not identified, homologs, or orthologs of >50% of the ATG
genes have been predicted by genomic searches (Brennand et al.,
2012). Several of these, including TOR1 and TOR2 involved
in first step of autophagy (Barquilla and Navarro, 2009) and
ATG3, ATG4, ATG5, ATG7, ATG10, and ATG12 involved
in vesicle expansion and completion step were characterized
in trypanosomatids by a gene knock-out approach (reviewed
in Brennand et al., 2012). T. cruzi epimastigotes subjected to
serum deprivation showed autophagic characteristics such
as accumulation of monodansylcadaverine-labeled vesicles
and redistribution of TcATG8 (Jimenez et al., 2008). Of the
two isoforms of TcATG8 (TcATG8.1 and TcATG8.2), only
TcATG8.1 was a bona fide ATG8/LC3 homolog that localized in
autophagosome-like vesicles in nutrient-starved T. cruzi (Alvarez
et al., 2008). Vanrell et al. (2017) found that TcATG8.1 expression
and mTOR-dependent autophagy were induced during early
stages of metacyclogenesis and showed that spermidine
and related polyamines positively regulated autophagy and
differentiation of epimastigote to metacyclic trypomastigote
form (Vanrell et al., 2017). Spermidine is essential for parasite
proliferation (González et al., 2001) and it is also a key metabolite
used for T[SH]2 synthesis. Others have shown the peroxide
concentrations (vs. antioxidant status) direct the parasite
differentiation and metacyclogenesis (Nogueira et al., 2015).
Together, these findings suggest that oxidants/antioxidants
balance and nutrients availability guide the parasite to induce
autophagy and metacyclogenesis, the two closely related
processes. Specifically, a fine balance of intracellular spermidine
and ROS levels likely determine proliferation, autophagy,
differentiation to metacyclic trypomastigote form, as well
as antioxidant capacity while the parasite gets ready to
enter the mammalian host. How parasite senses spermidine
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and ROS levels for such a fine-tuned cell cycle control is
still unknown.
Eukaryotic cells also utilize several additional approaches,
including ER-associated degradation (ERAD), lysosomal
proteases, and 20S proteasome complex to remove the
oxidized/degraded proteins (reviewed in Korovila et al.,
2017; Hwang and Qi, 2018). Trypanosomes lack an elaborated
ERAD network to recycle their proteins (Harbut et al., 2012).
Ubiquitin proteasome pathway (UPP)—an alternative system
for the turnover of damaged proteins—is expected to be present
based on the finding of 269 putative components of the UPP
pathway in T. cruzi proteome (Gupta et al., 2018). Some of
the UPP components are unique to T. cruzi, and are proposed
to be potential drug targets (Gupta et al., 2018). Specifically,
proteasome activity is detected in all life cycle stages of T.
cruzi, and its inhibition increased the carbonylated protein
content, resulting from formation of covalent, non-reversible
lipid aldehyde adducts on side chain of cysteine, histidine, and
lysine residues. Others have shown that treatment with specific
proteasome inhibitors blocked T. cruzi growth, metacyclogenesis
(Cardoso et al., 2008), and intracellular amastigote-to-
trypomastigote differentiation (González et al., 1996). Indeed,
proteasome-dependent proteolysis of carbonylated proteins that
were extensively present in late log phase epimastigote cultures
was suggested to signal metacyclogenesis (Cardoso et al., 2011).
Thus, it appears that ROS induction of protein damage and
protein degradation machinery might play an important role
in parasite development, though further in-depth studies are
needed to delineate the mechanistic role of ROS in regulating
protein degradation machineries in trypanosomes.
Nucleotides Synthesis and DNA
Replication
Cellular DNA synthesis and proliferation, as well as DNA repair
mechanisms depend on the production of a balanced supply
of deoxyribonucleotides (dNTPs). Ribonucleotide reductases
(RNRs) catalyze the de novo synthesis of dNTPs from the
corresponding ribonucleotides. Though RNRs are highly diverse,
their catalytic activity requires peptides harboring a free radical,
redox-active thiols, and proteins of the thioredoxin family, and,
therefore they are directly influenced by cell redox environment.
Indeed, a tight relationship between ROS level and DNA
replication is described in higher eukaryotes (Shackelford et al.,
2000; Burhans and Heintz, 2009). Macrophage production of
NO and NO donors inhibited DNA synthesis, likely through
NO-mediated inactivation of critical thiols on R1 subunit and
destruction of tyrosyl radical on the R2 subunit of RNRs
(Holmgren and Sengupta, 2010). Others showed that increased
levels of ROS dissociate replication accelerator-component
from the replisome complex and slow down DNA synthesis
as a safeguard for genome stability (Somyajit et al., 2017).
Importantly, it was shown that peroxiredoxin-2 (PRDX2), an
antioxidant enzyme, forms a replisome-associated ROS sensor
to regulate the replication machinery (Somyajit et al., 2017),
pointing out the relevance of the redox signaling/antioxidant
status in dNTP synthesis and DNA replication.
The finding of an inhibitory effect of oxidized forms of T[SH]2
and tryparedoxin on dNTP synthesis in T. brucei (Dormeyer
et al., 2001) offered the initial evidence for a relationship between
de novo nucleotide synthesis and redox status in trypanosomes.
Authors noted that tryparedoxins transfer the reducing energy
from T[SH]2 to RNR enzyme (Dormeyer et al., 2001). In T.
cruzi, we observed a direct correlation between the intracellular
T[SH]2 content and replication of epimastigotes (Mesías et al.,
2018). These observations suggest that T[SH]2−red/T[SH]2−ox
ratio, at least partially, regulates the DNA synthesis during
parasite proliferation. How the oxidant/antioxidant balance
couldmodulate genomic DNA replication inside parasite nucleus
remains to be understood in future studies.
Replication of parasite’s kinetoplast DNA (kDNA) is also
dependent on redox status. Kinetoplast is a unique DNA
structure present in a single large mitochondrion located close to
the nucleus of trypanosomatids. Each kinetoplast consists of 10–
20 copies of maxicircle DNA (20,000–40,000 bp) and 10,000 or
more copies of topologically interlockedminicircle DNA (<1,000
bp). Like mtDNA, maxicircles encode rRNAs and components
of the respiratory complexes. The heterogeneous sequences of
minicircle DNA encodes guide RNAs that function in mRNA
editing process (reviewed in Cavalcanti and De Souza, 2018).
The replication of minicircle DNA is a complex mechanism that
begins with the attachment of the universal minicircle sequence
(UMS), located at the origin of replication of minicircle DNA,
with the UMS binding protein (UMSBP), firstly identified in
Crithidia fasciculata (a related, non-pathogenic trypanosome)
(Tzfati et al., 1992) and more recently in T. cruzi (Coelho et al.,
2003). Recent studies showed that UMSBP affinity for target
kDNA and oligomerization was sensitive to redox potential in
C. fasciculata and Leishmania donovani (Onn et al., 2004; Singh
et al., 2016), and the reduction of UMSBP activates its binding
to the minicircle DNA origin site, whereas UMSBP oxidation
impaired this activity. Molecules of the antioxidant network,
TXN-II and TXNPx, were found to be involved in governing the
oxidized/reduced state of the UMSBP in C. fasciculata (Sela et al.,
2008). Further, deletion of UMSBP in Leishmania resulted in
decreased ATP production associated with reduced complex III
activity (Singh et al., 2016), an event that also results in increased
electron leakage and superoxide generation in mitochondria
(Wong et al., 2017).
Thus, parasite’s redox environment, modulated by its
antioxidant machinery, regulates dNTP synthesis, kDNA
replication, and oxidative phosphorylation that are necessary for
trypanosomes proliferation.
POSSIBLE FINE-TUNING MECHANISMS
OF T. CRUZI ANTIOXIDANT SYSTEM
As discussed above, T. cruzi is constantly exposed to ROS and
RNS throughout its life cycle and needs to effectively coordinate
the antioxidant and repair systems to overcome the toxic effects
of oxidative stress. These responses ought to be precise enough
to control the effects of the exogenous insult without altering
the cellular environment in the parasite, as this can affect other
cell signaling pathways. Even more, parasite has to assemble
specific responses according to the type of oxidative insult. This
section is focused on what we know, and mostly, what we do
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not know about how trypanosomes achieve fine-tuning of the
antioxidant system.
The unbiased transcriptomic and proteomic approaches have
shown that the expression and activity of the enzymes of
the antioxidant network are up-regulated in the infective and
intracellular stages of T. cruzi (Atwood et al., 2005; Parodi-Talice
et al., 2007; Zago et al., 2016). At least partly, one regulation
layer should reside on stage-specific mechanisms. Ribosome
profiling studies have indicated that T. cruzi, during the
infective metacyclic stage, exerts a translational control through
down-regulation of ribosomal components and up-regulation
of virulence factors (e.g., trans-sialidases) (Smircich et al.,
2015). Recent advances in chromatin proteomics have revealed
a substantial association between histone post-translational
modifications (PTMs) and stage-specific transition in T. cruzi
(De Jesus et al., 2016; Picchi et al., 2017) (Figure 3). What
is more interesting, some of the PTMs of histones were not
only novel and unusual, such as alternative lysine acetylation,
serine/threonine acetylation, and N-terminal methylation, but
also some of these PTMs were unique to T. cruzi and other
trypanosomes (De Jesus et al., 2016; Picchi et al., 2017). Thus,
it is likely that as T. cruzi undergoes stage-specific transitions
in multiple hosts, it employs histone’s modifications to organize
chromatin along with the traditional post-transcriptional and
translational mechanisms to drive the expression and activity
of its antioxidant network. This hypothesis remains to be
experimentally proven.
In trypanosomatids, gene expression is not regulated at
the transcription initiation level (reviewed in Teixeira and
DaRocha, 2003; Martínez-Calvillo et al., 2010; De Gaudenzi et al.,
2011). Instead, RNA-binding proteins (RBPs) that associate with
mRNAs and other regulatory proteins to form ribonucleoprotein
complexes (mRNPs) are suggested to exert post-transcriptional
regulation in trypanosomes. There are a wide variety of
RBPs, displaying different RNA binding domains, e.g., RNA-
recognition motif (RRM), pumilio and Fem-3-binding factor
(PUF), as well as zinc fingers (CCCH). Several RBPs were
described in T. cruzi (Alves and Goldenberg, 2016; Romaniuk
et al., 2016), and some were suggested to be involved in
stabilization (or destabilization) of mRNA in response to
extracellular stimuli (Fernández-Moya et al., 2012; Alves and
Goldenberg, 2016). Specifically, RBSR1 and the nuclear SR
protein TRRM1 were identified as nutritional stress-related RBPs
in T. cruzi (Wippel et al., 2018). T. cruzi may also employ
RBPs to form active or repressive mRNP complexes for post-
transcriptional regulation of antioxidant machinery in response
to other stress sources.
Other regulation layers may involve the microenvironment
within the parasite and the exogenous stimuli present in the
host environment. For example, RNA stress granules (SGs)
were proposed to regulate gene expression in response to
local stress (Protter and Parker, 2016; Khong et al., 2017).
SGs are ribonucleoprotein assemblies that incorporate different
components depending on the stimuli present (e.g., heat
shock, starvation, oxidative stress, etc.) to regulate the post-
transcriptional fate of mRNAs (Chen and Liu, 2017; Harvey
et al., 2017). These cytoplasmic foci act as traps for dispensable
mRNAs, and thereby, prevent new translation initiation until
the stress factor(s) have been removed (Rodrigues et al., 2010).
The occurrence of mammalian-like SGs and protein synthesis
arrest by eIF2α phosphorylation in response to stress was
described in T. cruzi (Tonelli et al., 2011). Further, uridine-
binding protein 1 and 2 (UBP1 and UBP2) that are present
in the nucleus in small amounts under normal conditions,
may accumulate in the cytoplasm under oxidative stress to
form RNA SGs and affect mRNA translation (Cassola et al.,
2007). Recent studies have demonstrated UBP1-dependent
translational repression as a mechanism for stage-specific
regulation of gene expression in T. cruzi (Romaniuk et al.,
2018) (Figure 3). DHH1, a DEAD box RNA helicase, is a
common component of both SGs and processing bodies (P-
bodies, constitutive RNA-granules); and it was described in
T. cruzi (Holetz et al., 2007). Interestingly, DHH1-containing
granules in T. cruzi were found to comprise a putative TryS-
coding transcript (Holetz et al., 2010), thus indicating that
SGs (and P-bodies) may also regulate the antioxidant response
in T. cruzi.
In higher eukaryotes, phosphorylation, acetylation, and
ubiquitination are usually ROS-sensitive PTMs (Liu et al., 2013;
Tseng et al., 2014). In T. cruzi and other trypanosomatids, PTM-
dependent regulation of signaling mechanisms is not studied in
detail. Schenkman and co-workers have recently developed the
acetylome of T. cruzi, and showed that some cytosolic enzymes
including antioxidant effectors were continuously acetylated and
deacetylated; presumably as a control system for their enzymatic
activity or protein-protein interaction (Moretti et al., 2018).
Further, a large-scale phosphoproteome analysis study showed
that antioxidant enzymes, TryR, TryS, and thiol-dependent
reductase 1, are major targets of phosphorylation during the
metacyclogenesis transition process (Marchini et al., 2011;
Amorim et al., 2017). Thus, PTMs could have a key role in
achieving a rapid regulation of antioxidants enzymatic activity as
well as in stage-specific modulation of antioxidants expression.
Additionally, some antioxidant enzymes are actively secreted by
the infective stages of T. cruzi (Bayer-santos et al., 2013; Gadelha
et al., 2013), and parasite may utilize this secretory pathway to
regulate the intracellular protein contents.
To sum up, parasite must elicit a rapid and precise response
toward oxidative stress and maintain redox homeostasis. It
appears that diverse mechanisms (i.e., chromatin modification,
RBPs, and PTMs) are involved in stage-specific regulation of
antioxidant gene expression during metacyclogenesis and in
infective/replicative forms of T. cruzi (Atwood et al., 2005;
Parodi-Talice et al., 2007; Zago et al., 2016). In addition, control
strategies (RBPs, stress granules conformation, PTMs) may also
be employed to fine-tune the adaptation to microenvironment.
Future research will provide precise information regarding the
specific regulation processes acting over antioxidant components
in each situation.
CONCLUSIONS AND REMARKS
In this review, we have discussed the different oxidative
challenges that parasite has to face throughout its life stages, the
mechanism(s) employed for controlling this condition, and the
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FIGURE 3 | Possible mechanisms controlling the antioxidant enzymes’ expression in trypanosomes. The expression of many of the antioxidant enzymes is increased
during metacyclogenesis and in infective stage suggesting that stage-specific regulation mechanism(s) are involved. (1) Stage-specific post-translational modifications
(PTMs) of histones are suggested to offer transcriptional regulation of antioxidants’ expression in different parasite life cycle stages. (2) RNA binding proteins (RBP) are
suggested to positively or negatively target the mRNA’s stability and offer post-transcriptional regulation. The RNA-granules containing ribosomal machinery are
suggested to arrest the translation of mRNAs for antioxidants. Overall, translational repression appears to be a general response during stress and in the infective
stages. (3) Post-translational modifications, especially acetylation and phosphorylation, of antioxidants may provide a tight regulation of the enzymatic activity. Further,
we propose that secretion of the antioxidants with extracellular vesicles (EV) acts as a mechanism to control intracellular concentration of antioxidants in the parasite.
cellular processes influenced by the parasite’s intracellular redox
environment. Further analysis of the interacting partners of the
antioxidant components could give us a deeper knowledge of
the pathways depending on redox balance. If we consider the
available interactomes in trypanosomes (Piñeyro et al., 2011b;
Arias et al., 2015; Peloso et al., 2016), it is clear that antioxidant
system is linked to many cellular pathways. It is our hope that
future investigations will focus on understanding the crosstalk
between antioxidants and other cellular processes and enhance
our understanding of the influence of redox balance on T.
cruzi biology.
Different drugs are assayed for the treatment of ChD and
sometimes their trypanocidal activity relies on their ability
to produce a redox imbalance over the parasite cell. Indeed,
nifurtimox and benznidazole, current drugs administered to
treat acute ChD, generate a non-specific oxidative effect
over pathogen macromolecules. Conversely, several naturally
produced antioxidant compounds (e.g., vitamins B12, C, K3, and
catechin) were also shown to have a degree of anti-parasitic effect
(Paveto et al., 2004; Ciccarelli et al., 2012; Desoti et al., 2015). In
some cases, the toxic effects of antioxidants were explained as
a consequence of ROS increase, produced by the redox cycling
process. In other words, antioxidant administration, like pro-
oxidants, may lead to a compromising cell redox imbalance
controlling parasite spread.
There is no doubt about the relevance of the antioxidant
network for rational drug design against trypanosomatids
(Piacenza et al., 2009b; Flohé, 2012; Talevi et al., 2018). The
deeper knowledge of the mechanisms involved in the regulation
of antioxidant responses in the different life cycle stages of the
parasite will provide better opportunities for designing new,
multi-component, parasite control strategies.
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